Annual EBITDA
-$64.26 M
-$26.94 M-72.19%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual EBITDA is -$64.26 million, with the most recent change of -$26.94 million (-72.19%) on December 31, 2023.
- During the last 3 years, IMCR annual EBITDA has risen by +$32.35 million (+33.48%).
- IMCR annual EBITDA is now -72.19% below its all-time high of -$37.32 million, reached on December 31, 2022.
Performance
IMCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$10.91 M
+$16.28 M+302.96%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly EBITDA is $10.91 million, with the most recent change of +$16.28 million (+302.96%) on September 30, 2024.
- Over the past year, IMCR quarterly EBITDA has increased by +$34.21 million (+146.81%).
- IMCR quarterly EBITDA is now at all-time high.
Performance
IMCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$37.60 M
+$7.78 M+17.14%
September 30, 2024
Summary
- As of February 8, 2025, IMCR TTM EBITDA is -$37.60 million, with the most recent change of +$7.78 million (+17.14%) on September 30, 2024.
- Over the past year, IMCR TTM EBITDA has increased by +$14.05 million (+27.20%).
- IMCR TTM EBITDA is now -19.08% below its all-time high of -$31.57 million, reached on March 31, 2023.
Performance
IMCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IMCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.2% | +146.8% | +27.2% |
| 3 y3 years | +33.5% | +127.8% | +75.6% |
| 5 y5 years | +40.3% | +127.8% | +75.6% |
IMCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | +72.0% | at high | +125.3% | -19.1% | +77.8% |
| 5 y | 5-year | -72.2% | +72.0% | at high | +124.1% | -19.1% | +77.8% |
| alltime | all time | -72.2% | +72.0% | at high | +124.1% | -19.1% | +77.8% |
Immunocore Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.91 M(-303.0%) | -$37.60 M(-17.1%) |
| Jun 2024 | - | -$5.37 M(-72.9%) | -$45.37 M(-16.8%) |
| Mar 2024 | - | -$19.83 M(-14.9%) | -$54.52 M(+5.6%) |
| Dec 2023 | -$64.26 M(+72.2%) | -$23.30 M(-844.6%) | -$51.65 M(+13.9%) |
| Sep 2023 | - | $3.13 M(-121.5%) | -$45.33 M(+14.6%) |
| Jun 2023 | - | -$14.52 M(-14.4%) | -$39.57 M(+25.3%) |
| Mar 2023 | - | -$16.95 M(-0.2%) | -$31.57 M(-7.2%) |
| Dec 2022 | -$37.32 M | -$16.99 M(-291.1%) | -$34.02 M(-43.5%) |
| Sep 2022 | - | $8.89 M(-236.3%) | -$60.23 M(-44.4%) |
| Jun 2022 | - | -$6.52 M(-66.4%) | -$108.36 M(-26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$19.40 M(-55.1%) | -$147.10 M(-13.0%) |
| Dec 2021 | -$229.36 M(+137.4%) | -$43.20 M(+10.1%) | -$169.00 M(+9.8%) |
| Sep 2021 | - | -$39.24 M(-13.3%) | -$153.95 M(+8.7%) |
| Jun 2021 | - | -$45.26 M(+9.6%) | -$141.60 M(+19.5%) |
| Mar 2021 | - | -$41.31 M(+46.8%) | -$118.52 M(+18.0%) |
| Dec 2020 | -$96.61 M(-33.1%) | -$28.14 M(+4.6%) | -$100.42 M(-12.6%) |
| Sep 2020 | - | -$26.89 M(+21.2%) | -$114.85 M(+30.6%) |
| Jun 2020 | - | -$22.19 M(-4.4%) | -$87.96 M(+33.7%) |
| Mar 2020 | - | -$23.21 M(-45.5%) | -$65.77 M(+54.5%) |
| Dec 2019 | -$144.51 M(+34.3%) | -$42.57 M | -$42.57 M |
| Dec 2018 | -$107.58 M | - | - |
FAQ
- What is Immunocore Holdings annual EBITDA?
- What is the all time high annual EBITDA for Immunocore Holdings?
- What is Immunocore Holdings annual EBITDA year-on-year change?
- What is Immunocore Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Immunocore Holdings?
- What is Immunocore Holdings quarterly EBITDA year-on-year change?
- What is Immunocore Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Immunocore Holdings?
- What is Immunocore Holdings TTM EBITDA year-on-year change?
What is Immunocore Holdings annual EBITDA?
The current annual EBITDA of IMCR is -$64.26 M
What is the all time high annual EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high annual EBITDA is -$37.32 M
What is Immunocore Holdings annual EBITDA year-on-year change?
Over the past year, IMCR annual EBITDA has changed by -$26.94 M (-72.19%)
What is Immunocore Holdings quarterly EBITDA?
The current quarterly EBITDA of IMCR is $10.91 M
What is the all time high quarterly EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high quarterly EBITDA is $10.91 M
What is Immunocore Holdings quarterly EBITDA year-on-year change?
Over the past year, IMCR quarterly EBITDA has changed by +$34.21 M (+146.81%)
What is Immunocore Holdings TTM EBITDA?
The current TTM EBITDA of IMCR is -$37.60 M
What is the all time high TTM EBITDA for Immunocore Holdings?
Immunocore Holdings all-time high TTM EBITDA is -$31.57 M
What is Immunocore Holdings TTM EBITDA year-on-year change?
Over the past year, IMCR TTM EBITDA has changed by +$14.05 M (+27.20%)